ELYM (Eliem Therapeutics) Kompaniyaning sof daromadi

eliemtx.com (ELYM) kompaniyasining rasmiy ramzlari

Geopolitik keskinliklar reagentlar logistikasi va xalqaro ilmiy hamkorlikni murakkablashtirmoqda. GURU.Markets grafigida ko'rsatilganidek, Eliem Therapeutics (ELYM) kompaniyasining sof sof foydasi barqaror tendentsiyani namoyish etmoqda, bunda -0.06 darajasi joriy qiymatni ifodalaydi. Rivojlanish opsionlarga asoslangan rag'batlantirish tizimiga ega neyrobiologlar xodimlariga tayanadi, joriy strategiya esa gematologiya biotexnologiya kompaniyasi bilan integratsiyadan so'ng FDA protokollariga asoslangan.

ELYM: Eliem Therapeutics Sof foyda 04.07.2022 - 03.10.2024

eliemtx.com (ELYM) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Eliem Therapeutics Inc.|ELYM - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor qiymati Eliem Therapeutics Inc.|ELYM - Kompaniyaning to‘liq qiymati
- balans bo'yicha xususiy kapital ma'lumotlari:
Bitta aksiya uchun sof aktivlar Eliem Therapeutics|ELYM - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi eliemtx.com|ELYM - Kompaniyaning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning kapitalga nisbati Eliem Therapeutics|ELYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Eliem Therapeutics Inc.|ELYM - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Eliem Therapeutics Inc.|ELYM - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli majburiyatlar miqdori Eliem Therapeutics|Oraliq qoplash koeffitsiyenti eliemtx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ELYM - Sof foyda
Kompaniyaning jamlanma tahlili:Eliem (ELYM)
Eliem Therapeutics, Inc. brend mahsuloti

Emitentning moliyaviy barqarorligini baholayotgan investor uchun ushbu ko'rsatkich treyderlar kutganlari asosida har kuni hisoblanadigan, joriy biznes daromadliligiga oid bozor konsensusini aks ettiradi. Eliem Therapeutics (ELYM) foyda dinamikasini tahlil qilish orqali epilepsiya dori vositalarini ishlab chiqishga tadqiqot va ishlanmalar (R&D) xarajatlarining ta'sirini kuzatish mumkin, bunda grafikdagi har qanday og'ishlar ilmiy salohiyatning qayta baholanishi yoki operatsion xarajatlarning oshishidan dalolat beradi.

Muhim raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Kompaniyaning sof daromadi regencellbioscience.com RGC|Kompaniyaning sof foydasi Axsome Therapeutics, Inc. (AXSM)|Kompaniyaning sof foydasi ACAD (ACADIA Pharma)|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Sof moliyaviy natija Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Sof foyda|Kompaniyaning sof daromadi catalystpharma.com|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Sof daromad Harmony Biosciences Inc|Sof daromad BHVN|AMLX: Yakuniy foyda|Sof daromad TRVI (Trevi Therapeutics)|Soliqlar to‘langandan keyingi foyda PRAX|Sof foyda AVXL (Anavex Life Sciences Corp.)|Yakuniy foyda CBLL|Prothena Biosciences - Sof foyda|Kompaniyaning sof daromadi Alector, Inc.|Annexon, Inc. (ANNX) - Kompaniyaning sof foydasi|Omeros - Yakuniy foyda|NGNE (Neurogene) - Sof foyda|Sof foyda AC Immune S.A.|Kompaniyaning sof foydasi Voyager Pharma (VYGR)|NMRA: Soliqdan keyingi foyda|Sof foyda SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Kompaniyaning sof daromadi|ACOG: Sof daromad|CGTX - Sof foyda|IKT (Inhibikase) - Sof daromad|SAVA: Soliqlar to‘langandan keyingi foyda|ASRT (Assertio Holdings) - Sof foyda|Coya (COYA) - Sof moliyaviy natija|Sof foyda VTGN|Sof daromad ovidrx.com OVID|Kompaniyaning sof foydasi Acumen Pharma ABOS|Sof moliyaviy natija CervoMed Corporation (CRVO)|Alterity Therapeutics Ltd - Sof foyda|Kompaniyaning sof daromadi Clene Inc.|pepgen.com (PEPG) - Kompaniyaning sof foydasi|JUNS (jupiterneurosciences.com) - Kompaniyaning sof foydasi|Sof daromad RLMD|Kompaniyaning sof daromadi Annovis Bio Corporation ANVS|Kompaniyaning sof foydasi Grace Therapeutics, Inc. (GRCE)|Sof daromad fireflyneuro.com AIFF|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|NRSN: Kompaniya foydasi|Reviva Pharmaceuticals Holdings - Sof foyda|Kompaniyaning sof daromadi MetaVia Inc|NRXS (NeurAxis, Inc.) - Sof daromad|Helius Medical Technologies (HSDT) - Sof foyda|Kompaniyaning sof foydasi Passage Bio Inc.|NEUP: Yakuniy foyda|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|ATHA - Kompaniyaning sof daromadi|Sof foyda ADXN (Addex Therapeutics)|Alzamend Neuro Inc. (ALZN) - Kompaniyaning sof daromadi|CYCN - Kompaniyaning sof foydasi|PTIX: Kompaniyaning sof foydasi|KTTA: Sof foyda|CRGT - Sof moliyaviy natija|ATXI (Avenue Therapeutics) - Sof foyda|Kompaniyaning sof daromadi brainstorm-cell.com BCLI|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|Sof daromad Chromocell Therapeutics Corp CHRO|Intra-Cellular Therapies, Inc. - Sof daromad|Yakuniy foyda LBPH|MRNS: Sof daromad|nkgenbiotech.com - Soliqlar to‘langandan keyingi foyda|NRBO: Sof foyda|Sage Therapeutics Inc. - Yakuniy foyda|SNPX (Neurotrope) - Sof foyda|Kompaniyaning sof daromadi Trevena Inc TRVN|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|WENA (Anew Medical Inc.) - Yakuniy foyda|Sof foyda CERE (Cerevel Therapeutics, Inc.)